J.P. Venetz

Discipline

Psychologie (3) Sociologie (1)

Type de document

Articles (18) Recensions (4)

Co-auteur

Date

Source

Mot-clé

Patients (13) Patients (13) Transplantation (12) Treatment (11) Human beings (10) risque (6) organe (6) Risk (6) Organ (Musical instrument) (6) Immunosuppression (6) Organs (6) orgue (6) thérapie (5) infection (5) effet (5) Therapeutics (5) Months (5) Infection (5) puits (4) association (4) adulte (4) Case (4) Control (4) FK-506 (Drug) (4) Transplantation of organs, tissues, etc (4) Social groups (4) Grammar, Comparative and general--Case (4) Case (4) Blood (4) Older people (4)

Documents écrit par J.P. Venetz (18) | parle de J.P. Venetz (0)

Prise en charge des maladies rénales génétiques : expérience locale et importance du réseau [Management of genetic renal disorders: local experience and importance of the network]
O. Bonny et al. (21 juin 2023)
Incidence, Risk Factors, and Management of Incisional Hernias After Kidney Transplant: A 20-Year Single Center Experience.
L. Costa et al.
Case Report: A Rare Truncating Variant of the CFHR5 Gene in IgA Nephropathy.
G. Guzzo et al. (2021)
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study.
N. Perrottet et al. (2021)
Upfront use of eculizumab to treat early acute antibody-mediated rejection after kidney allotransplantation and relevance for xenotransplantation.
N. Schwotzer et al.
Infection à SARS-CoV-2 et transplantation d’organes solides [SARS-CoV-2 infection and solid organ transplantation]
D. Golshayan et al. (29 avr. 2020)
Syndrome d’Alagille [Alagille Syndrome]
J. Wakim El-Khoury et al. (28 août 2019)
Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients.
L. Quteineh et al.
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.
Y.D. Muller et al.
Multimodal imaging of retinal pigment epithelial detachments in patients with C3 glomerulopathy: case report and review of the literature.
V. Kheir et al. (22 nov. 2017)
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.
L. Quteineh et al.
Immunosuppressive therapy after solid-organ transplantation: does the INTERMED identify patients at risk of poor adherence?
L. Michaud et al. (2016)
Absence of mTOR Inhibitor Effect on Hepatic Cyst Growth: A Case Report of a Kidney Transplant Recipient with Autosomal Dominant Polycystic Kidney Disease.
L. Friedrich et al. (2012)
Late onset tacrolimus-induced life-threatening polyneuropathy in a kidney transplant recipient patient
D. Renard et al. (2012)
Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients.
O. Manuel et al. (2011)
Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients.
N. Perrottet et al. (2008)
Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients.
L. Codarri et al. (2007)
Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation.
O. Manuel et al. (2007)